Last10K.com

Illumina Inc (ILMN) SEC Filing 10-Q Quarterly report for the period ending Sunday, September 30, 2018

SEC Filings

Illumina Inc

CIK: 1110803 Ticker: ILMN
                                        
 
 
 
 
Investors:
ilmnlogoa09.jpg
 
 
Jacquie Ross, CFA
 
 
858-882-2172
 
 
ir@illumina.com
 
 
 
 
 
 
 
Media:
 
 
 
 
Eric Endicott
 
 
 
 
858-882-6822
 
 
 
 
pr@illumina.com

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2018

San Diego -- (BUSINESS WIRE) - October 23, 2018 - Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the third quarter of fiscal year 2018.

Third quarter 2018 results:
Revenue of $853 million, a 20% increase compared to $714 million in the third quarter of 2017
GAAP net income attributable to Illumina stockholders for the quarter of $199 million, or $1.33 per diluted share, compared to $163 million, or $1.11 per diluted share, for the third quarter of 2017
Non-GAAP net income attributable to Illumina stockholders for the quarter of $227 million, or $1.52 per diluted share, compared to $163 million, or $1.11 per diluted share, for the third quarter of 2017 (see the table entitled “Itemized Reconciliation Between GAAP and Non-GAAP Net Income Attributable to Illumina Stockholders” for a reconciliation of these GAAP and non-GAAP financial measures)
Cash flow from operations of $292 million compared to $235 million in the third quarter of 2017
Free cash flow (cash flow from operations less capital expenditures) of $228 million for the quarter, compared to $153 million in the third quarter of 2017

Gross margin in the third quarter of 2018 was 70.0% compared to 67.5% in the prior year period. Excluding amortization of acquired intangible assets, non-GAAP gross margin was 71.1% for the third quarter of 2018 compared to 68.8% in the prior year period.

Research and development (R&D) expenses for the third quarter of 2018 were $159 million compared to $134 million in the prior year period. Non-GAAP R&D expenses as a percentage of revenue were 18.6%, including 0.9% attributable to Helix. This compares to non-GAAP R&D expenses as a percentage of revenue of 18.7% in the prior year period, including 0.8% attributable to Helix.

Selling, general and administrative (SG&A) expenses for the third quarter of 2018 were $197 million compared to $167 million in the prior year period. Non-GAAP SG&A expenses as a percentage of revenue were 23.2%, including 1.4% attributable to Helix. This compares to 23.2% in the prior year period, including 1.7% attributable to Helix.

Depreciation and amortization expenses were $46 million and capital expenditures for free cash flow purposes were $64 million during the third quarter of 2018. At the close of the quarter, the company held $3.4 billion in cash, cash equivalents and short-term investments, compared to $2.1 billion as of December 31, 2017.

“Illumina’s strong performance in the third quarter of 2018 reflected growth across our sequencing and arrays portfolios,” said Francis deSouza, President and CEO. “Sequencing system revenue of $138 million was the strongest since 2015, reflecting strong demand within our sequencing family from the NovaSeq, the most powerful and flexible sequencer ever, to the iSeq, our most accessible and easiest-to-use sequencer.”



The following information was filed by Illumina Inc (ILMN) on Tuesday, October 23, 2018 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Illumina Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Illumina Inc.

Continue

Assess how Illumina Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Illumina Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
M & A
Other
Filter Subcategory:
All
Earnings
Expense
Cash Flow
Product
Income
Shares
Other
Inside Illumina Inc's 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Condensed Consolidated Balance Sheets
Condensed Consolidated Statement Of Stockholders' Equity Statement
Condensed Consolidated Statements Of Cash Flows
Condensed Consolidated Statements Of Comprehensive Income
Condensed Consolidated Statements Of Income
Balance Sheet Account Details
Balance Sheet Account Details (Tables)
Balance Sheet Account Details - Narrative - Deconsolidation Of Grail, Inc. (Details)
Balance Sheet Account Details - Narrative - Derivatives (Details)
Balance Sheet Account Details - Narrative - Intangible Assets And Goodwill (Details)
Balance Sheet Account Details - Narrative - Investments In Consolidated Variable Interest Entities (Details)
Balance Sheet Account Details - Narrative - Property And Equipment (Details)
Balance Sheet Account Details - Narrative - Strategic Investments (Details)
Balance Sheet Account Details - Narrative - Warranties (Details)
Balance Sheet Account Details - Summary Of Accrued Liabilities (Details)
Balance Sheet Account Details - Summary Of Activity Of Redeemable Noncontrolling Interests (Details)
Balance Sheet Account Details - Summary Of Changes In Goodwill (Details)
Balance Sheet Account Details - Summary Of Changes In Reserve For Product Warranties (Details)
Balance Sheet Account Details - Summary Of Contractual Maturities Of Available-For-Sale Debt Securities (Details)
Balance Sheet Account Details - Summary Of Inventory (Details)
Balance Sheet Account Details - Summary Of Property And Equipment (Details)
Balance Sheet Account Details - Summary Of Short-Term Investments (Details)
Basis Of Presentation And Summary Of Significant Accounting Policies
Basis Of Presentation And Summary Of Significant Accounting Policies (Policies)
Basis Of Presentation And Summary Of Significant Accounting Policies (Tables)
Basis Of Presentation And Summary Of Significant Accounting Policies - Narrative (Details)
Basis Of Presentation And Summary Of Significant Accounting Policies - Recently Adopted Accounting Principles (Details)
Basis Of Presentation And Summary Of Significant Accounting Policies - Summary Of Calculation Of Weighted Average Shares Used To Calculate Basic And Diluted Earnings Per Share (Details)
Debt And Other Commitments
Debt And Other Commitments (Tables)
Debt And Other Commitments - Build-To-Suit Leases Narrative (Details)
Debt And Other Commitments - Narrative (Details)
Debt And Other Commitments - Summary Of Debt Obligations (Details)
Fair Value Measurements
Fair Value Measurements (Tables)
Fair Value Measurements - Summary Of Hierarchy For Assets And Liabilities Measured At Fair Value On A Recurring Basis (Details)
Income Taxes
Income Taxes - Narrative (Details)
Legal Proceedings
Segment Information
Segment Information (Details)
Segment Information (Tables)
Share-Based Compensation Expense
Share-Based Compensation Expense (Tables)
Share-Based Compensation Expense - Narrative (Details)
Share-Based Compensation Expense - Summary Of Assumptions Used To Estimate The Weighted-Average Fair Value Per Share For Stock Purchase Under The Employee Stock Purchase Plan (Details)
Share-Based Compensation Expense - Summary Of Share-Based Compensation Expense For All Stock Awards (Details)
Stockholders' Equity
Stockholders' Equity (Tables)
Stockholders' Equity - Narrative (Details)
Stockholders' Equity - Narrative - Employee Stock Purchase Plan (Details)
Stockholders' Equity - Narrative - Share Repurchases (Details)
Stockholders' Equity - Summary Of Restricted Stock Activity And Related Information (Details)
Stockholders' Equity - Summary Of Stock Option Activity Under All Stock Option Plans (Details)

Material Contracts, Statements, Certifications & more

Illumina Inc provided additional information to their SEC Filing as exhibits

Ticker: ILMN
CIK: 1110803
Form Type: 10-Q Quarterly Report
Accession Number: 0001110803-18-000031
Submitted to the SEC: Tue Oct 23 2018 7:46:12 PM EST
Accepted by the SEC: Wed Oct 24 2018
Period: Sunday, September 30, 2018
Industry: Laboratory Analytical Instruments

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/ilmn/0001110803-18-000031.htm